2 completed, 1 recruiting. 3 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 2, Recruiting 1 |
| Phase 1 | 2 | Completed 2 |
Follow Clear Cell Renal Cell Carcinoma Metastatic: new trials by email Literature Review of Clear Cell Renal Cell Carcinoma Metastatic trials Research Report on Clear Cell Renal Cell Carcinoma Metastatic
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Zanzalintinib for Metastatic Clear Cell Renal Cell Carcinoma With Bone Metastases Zanzalintinib, Investigator Choice of Bone Strengthening Agents (BSA), Non-Investigational Radiation Therapy (RT) - Clear Cell Renal Cell Cancer (ccRCC), Clear Cell Renal Carcinoma | Phase 2 | Recruiting | Kelly Fitzgerald, MD | 20 | 2026-06-10 | 2026-07-27 |
| Pharmacokinetics, Biodistribution, Radiation Dose and Safety Study of 68Ga-NYM005 in Patients 68Ga-NYM005 injection - Clear Cell Renal Cell Carcinoma Metastatic | Phase 1 / Phase 2 | Completed | Norroy Bioscience Co., LTD | 19 | 2024-06-17 | 2025-05-21 |
| Seleno-L Methionine (SLM)-Axitinib-Pembrolizumab Selenomethionine (SLM), Axitinib, Pembrolizumab - Clear Cell Renal Cell Carcinoma, Clear Cell Renal Cell Carcinoma Metastatic | Phase 1 / Phase 2 | Completed | Fernando Maciel Barbosa | 15 | 2022-09-19 | 2026-11-02 |
Clear-cell metastatic renal cell carcinoma (3) · Carcinoma, Renal Cell (2) · Neoplasm Metastasis (1)
Adenocarcinoma (2) · Carcinoma (2) · Female Urogenital Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (2) · Kidney Diseases (2) · Kidney Neoplasms (2) · Male Urogenital Diseases (2) · Neoplasms (2) · Neoplasms by Histologic Type (2) · Neoplasms by Site (2) · Neoplasms, Glandular and Epithelial (2) · Urogenital Diseases (2) · Urogenital Neoplasms (2) · Urologic Diseases (2) · Urologic Neoplasms (2)
Axitinib (1) · Denosumab (1) · Diphosphonates (1) · Ibandronic Acid (1) · Radiotherapy (1) · Selenomethionine (1) · Zoledronic Acid (1) · pembrolizumab (1)
Fernando Maciel Barbosa (1) · Kelly Fitzgerald, MD (1) · Norroy Bioscience Co., LTD (1)
United States (2) · China (1)
Kelly Fitzgerald, MD (1) · Mohammed Milhem, MD (1)